Natco Pharma Limited updates on dispute with FMC Corporation

Natco Pharma Limited (NSE: NATCOPHARM, BSE: 524816) states that the Hon'ble High Court of Delhi has today orally pronounced judgment in the interim injunction application filed by FMC Corporation on CTPR. The Hon'ble Court said that it has allowed the application of FMC Corporation. The full copy of the Judgment is yet to become available. Natco will review all its options after the full Judgment becomes available to it.

Shares of NATCO PHARMA LTD. was last trading in BSE at Rs.1164.85 as compared to the previous close of Rs. 1157.1. The total number of shares traded during the day was 18888 in over 1221 trades.

The stock hit an intraday high of Rs. 1188.05 and intraday low of 1156.5. The net turnover during the day was Rs. 22121861.

Source : Equity Bulls

Keywords